Welcome to the CJU website » LOG IN


Stability of reconstituted freeze-dried Bacille Calmette-Guérin used for intravesical immunotherapy for bladder cancer
Department of Medicine and Microbiology, University of Toronto, The Toronto Hos
Oct  1998 (Vol.  5, Issue  4, Pages( 608 - 610)


Text-Size + 

  • The product monographs for the commercially available products of Bacille Calmette-Guérin (BCG) state they must be used immediately following reconstitution. We hypothesized that the viability of the reconstituted preparations of BCG would not be altered for a period of up to 4 hours thus allowing a longer time interval between full preparation and its intravesical administration. Vials of freeze-dried ImmuCyst™ (Connaught Laboratories) and TICE™ BCG (Organon-Teknika) were fully reconstituted in approximately 50 ml of saline and aliquots of the fully reconstituted product were serially diluted and inoculated onto freshly prepared Lowenstein-Jensen slants and colony counts were conducted at 0, 2, and 4 hours. The colony counts of the freeze-dried preparations of BCG varied between 0.1 and 0.3 x 108 and between 0.6 and 1.1 x 108 per reconstituted volume at 4 hours for the Connaught and TICE strains, respectively. There was no decrease in the colony counts between 0 and 4 hours for either product. There were no significant differences in the viability of the fully reconstituted freeze-dried preparation of BCG for up to 4 hours after complete reconstitution. These findings would suggest some latitude may be provided for institutions where the product is fully reconstituted prior to its actual administration.

Current Issue

December 2021, Vol.28 No.6
canadian journal of urology